IGC Pharma (IGC) Receivables - Other (2016 - 2025)
Historic Receivables - Other for Pharma (IGC) over the last 17 years, with Q3 2025 value amounting to $670000.0.
- Pharma's Receivables - Other fell 218.98% to $670000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $670000.0, marking a year-over-year decrease of 218.98%. This contributed to the annual value of $680000.0 for FY2025, which is 87.46% down from last year.
- According to the latest figures from Q3 2025, Pharma's Receivables - Other is $670000.0, which was down 218.98% from $680000.0 recorded in Q2 2025.
- In the past 5 years, Pharma's Receivables - Other registered a high of $951000.0 during Q1 2023, and its lowest value of $354000.0 during Q2 2022.
- Over the past 5 years, Pharma's median Receivables - Other value was $680000.0 (recorded in 2025), while the average stood at $647368.4.
- In the last 5 years, Pharma's Receivables - Other soared by 16864.41% in 2023 and then crashed by 2822.41% in 2024.
- Over the past 5 years, Pharma's Receivables - Other (Quarter) stood at $382000.0 in 2021, then skyrocketed by 96.6% to $751000.0 in 2022, then grew by 25.97% to $946000.0 in 2023, then decreased by 28.22% to $679000.0 in 2024, then dropped by 1.33% to $670000.0 in 2025.
- Its Receivables - Other was $670000.0 in Q3 2025, compared to $680000.0 in Q2 2025 and $680000.0 in Q1 2025.